Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis
Open accessThe DOI matches its Crossref record; 68 of the 69 references it cites were found in a registry or an index; 36 of the 74 sources its claims cite were checked for support.
Abstract
Despite its abundance in the environment, iron is poorly bioavailable and subject to strict conservation and internal recycling by most organisms. In vertebrates, the stability of iron concentration in plasma and extracellular fluid, and the total body iron content are maintained by the interaction of the iron-regulatory peptide hormone hepcidin with its receptor and cellular iron exporter ferroportin (SLC40a1). Ferroportin exports iron from duodenal enterocytes that absorb dietary iron, from iron-recycling macrophages in the spleen and the liver, and from iron-storing hepatocytes. Hepcidin blocks iron export through ferroportin, causing hypoferremia. During iron deficiency or after hemorrhage, hepcidin decreases to allow iron delivery to plasma through ferroportin, thus promoting compensatory erythropoiesis. As a host defense mediator, hepcidin increases in response to infection and inflammation, blocking iron delivery through ferroportin to blood plasma, thus limiting iron availability to invading microbes. Genetic diseases that decrease hepcidin synthesis or disrupt hepcidin binding to ferroportin cause the iron overload disorder hereditary hemochromatosis. The opposite phenotype, iron restriction or iron deficiency, can result from genetic or inflammatory overproduction of hepcidin.
Overview
CoChat Summary
TL;DR
The review describes how hepcidin binding to ferroportin controls systemic iron homeostasis by blocking cellular iron export, thereby regulating plasma iron, erythropoiesis, and host defense. Dysregulation of this axis causes iron overload such as hereditary hemochromatosis or iron-restrictive anemias, making it a therapeutic target.
Key findings
- Hepcidin, a 25-amino-acid peptide (MW 2.8 kD) present at approximately 2–20 nM in healthy humans, binds ferroportin (SLC40A1; 571 amino acids, ~65–70 kD) and inhibits iron export by occluding the open-outward conformation and inducing endocytosis/degradation.
- Ferroportin exports iron from duodenal enterocytes, iron-recycling macrophages, and hepatocytes; adult humans have total body iron of approximately 3–4 g with daily losses of only 1–2 mg, while plasma transferrin holds only 2–3 mg of iron but delivers 20–25 mg/day.
- The erythron contains approximately 2–3 g of iron, about 2/3–3/4 of total body iron; hepatocyte stores contain up to 1 g, the spleen normally about 0.05 g, and other tissues about 0.3 g.
- Loss of hepcidin or disrupted hepcidin binding to ferroportin causes hereditary hemochromatosis; excessive hepcidin, such as from TMPRSS6 mutations, causes iron-refractory iron deficiency anemia (IRIDA), and inflammatory hepcidin increases produce hypoferremia and nutritional immunity.
Methods
- Narrative review synthesizing published literature; no primary experimental design, sample, or statistical analysis is reported.
- The text integrates structural, genetic, physiological, and clinical evidence from cited studies, including mouse models and human disease examples.
- Not stated in the paper: systematic search strategy, inclusion/exclusion criteria, or data-extraction methods.
Limitations
- The paper states unresolved issues: how ferroportin’s two divalent metal-binding sites mediate export is not clear; the energetics of iron export are not well characterized; functional consequences of tissue-specific ferroportin glycosylation are not understood; the quantitative contribution of hepcidin clearance mechanisms is unknown; and the physiological role of microRNA regulation is uncertain.
- Evident from the text: as a narrative review, it lacks a described systematic search or formal quality assessment, so conclusions depend on selected cited literature.
- Not stated in the paper: an explicit limitations section or discussion of publication bias.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 A current model of hepcidin (orange) interaction with ferroportin (blue) in which binding is dependent on iron (green). The framework of helices that make up ferroportin are depicted as cylinders connected by extracellular and intracellular disordered loops. The side chains that make up the binding sites for iron are shown. Modified from [14].](https://figures.cochat.ai/paper-figures/a8d0b48e97e349ad9b7b164106596b50/hepcidin-ferroportin-interaction-controls-systemic-iron-homeostasis-figure-3.jpg)


Verification
Claims the paper makes
31 Valid · 2 Not valid · 28 Not checked · 21 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Because iron is exported against the force exerted by the transmembrane electric field, and there is no evidence of direct coupling of the transport to ATP hydrolysis, the export of iron is likely facilitated by the coupled “downhill” transport of another ion or small molecule [13].”
§ Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis > 4. Ferroportin Structure
What the sources say
- Disputedcites [13] Deshpande, 2018, Calcium is an essential cofactor for metal efflux by the ferroportin transporter family, Nat. Commun. sourceExperimental — accuracy not yet measured
The Results section reports that iron efflux does not depend on a transmembrane H+ gradient or Na+, and experiments do not support Fe2+/Ca2+ antiport. The paper instead identifies extracellular Ca2+ as a cofactor that activates ferroportin without being transported. These findings run contrary to the proposed downhill-coupled transport mechanism. (LLM, conf=0.84)
Checked by a reasoning model — may be wrong.
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on 2 assumptions not shown here.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Efficient filtration of hepcidin in the glomerulus is facilitated by the relatively low fraction of hepcidin that is bound by plasma protein, estimated at about 40% [28].”
§ Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis > 6. Hepcidin Synthesis and Elimination
What the sources say
- Partly supportedcites [28] Diepeveen, L.E., Laarakkers, C.M., Peters, H.P.E., van Herwaarden, A.E., Groenewoud, H., IntHout, J., Wetzels, J.F., van Swelm, R.P.L., and Swinkels, D.W. (2019). Unraveling hepcidin plasma protein binding: Evidence from peritoneal equilibration testing. Pharmaceuticals, 12. sourceExperimental — accuracy not yet measured
The Abstract reports a hepcidin protein-bound fraction of 40% (±23%), and the Discussion says hepcidin is not predominantly bound and is rapidly excreted by the kidneys. The study used peritoneal dialysis in patients with end-stage renal disease; it does not establish that low protein binding facilitates efficient filtration in the glomerulus. (LLM, conf=0.86)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“A recent study [21] provide convincing evidence that Rnf217 is an important E3 ubiquitin ligase that triggers the degradation of ferroportin in response to hepcidin binding.”
§ Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis > 5. Ferroportin Interactions with Hepcidin
What the sources say
- Supportedcites [21] Jiang, L., Wang, J., Wang, K., Wang, H., Wu, Q., Yang, C., Yu, Y., Ni, P., Zhong, Y., and Song, Z. (2021). RNF217 regulates iron homeostasis through its E3 ubiquitin ligase activity by modulating ferroportin degradation. Blood. source
The Introduction states that hepcidin binds ferroportin and induces its internalization and degradation. The Results report that RNF217’s E3 ubiquitin ligase activity is required for ferroportin degradation and that hepcidin-mediated degradation is at least partially RNF217-dependent in mice. The paper also notes that RNF217 can promote degradation without added hepcidin in vitro, so the response to hepcidin is not its only observed mode of action. (LLM, conf=0.91)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Moreover, duodenal iron absorption increases several-fold after blood loss or exposure to hypoxia, or in response to iron deficiency.”
§ Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis > 2. Iron Compartments and Flows
What the sources say
- Partly supportedcites [3] Finch, 1994, Regulators of iron balance in humans, Blood sourceExperimental — accuracy not yet measured
The Store Regulator (p. 2) says absorption is high when iron stores are depleted, and The Erythroid-Regulator (p. 3) reports increased absorption after phlebotomy and in iron-deficiency anemia. The latter section links hypoxia to erythropoietin release, but does not report a several-fold rise in duodenal absorption after hypoxia exposure; it also does not establish a several-fold increase for each condition in the claim. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The model also revealed an important unexpected feature, the indication that the suspected hepcidin-binding site in the C-lobe, centered on the critically important C325 thiol cysteine, utilizes an iron atom to coordinate hepcidin binding [14].”
§ Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis > 5. Ferroportin Interactions with Hepcidin
What the sources say
- Partly supportedcites [14] Billesbolle, 2020, Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms, Nature sourceExperimental — accuracy not yet measured
The hepcidin-binding section (p. 6) supports the role of a C-domain metal site: iron greatly increases hepcidin affinity, and mutations at that site weaken binding. But the cited paper identifies the coordinating cysteine as C326, not C325; C325 is not the cysteine named in this claim. The structure directly shows cobalt, an iron mimetic, at the site. (LLM, conf=0.92)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
44 more claims · 19 with their cited sources checked
Create a free account to see all 82 claims and to verify the 10 references still open.
- It may state two separate claims as one. 31
- Probably not a substantial claim. 3
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis > 5. Ferroportin Interactions with Hepcidin
“the suspected hepcidin-binding site in the C-lobe, centered on the critically important C325 thiol cysteine”
§ Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis > 7. Evidence for Exclusivity of the Hepcidin-Ferroportin Ligand-Receptor Dyad
“the essential conserved amino acid at the ferroportin binding site for hepcidin, C326 (human numbering)”
Citations
Cites
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803 · cited 3×
“The flow of iron out of the cells is controlled by hepcidin through two known mechanisms: occlusion of the open-outward conformation of ferroportin by hepcidin [17], and hepcidin-induced endocytosis and degradation of ferroportin [4].”
BackgroundSelf-citationNemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420945 · Cited by 2,650 · cited 2×
“Infection and inflammation induce hepcidin, predominantly through the effects of the cytokine interleukin-6 (IL-6) [52], and increased concentrations of hepcidin then inhibit ferroportin activity, leading to depletion of iron in plasma and extracellular fluid (hypoferremia).”
BackgroundSelf-citationHepcidin, a urinary antimicrobial peptide synthesized in the liver
Park, C. H., Valore, E. V., Waring, A. J., & Ganz, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008922200 · Cited by 2,168 · cited 1×
“Hepcidin can also kill microbes on contact in vitro [59,60] but the concentrations required for this direct microbicidal activity exceeded its concentrations in extracellular fluid, even in inflamed models.”
BackgroundSelf-citationPositional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter
Donovan, A., Brownlie, A., Zhou, Y., Shepard, J., Pratt, S. J., Moynihan, J., Paw, B. H., Drejer, A., Barut, B., Zapata, A., et al. (2000) · Nature · doi:10.1038/35001596 · Cited by 1,667 · cited 1×
“During pregnancy, ferroportin is very highly expressed on the basal surface of syncytiotrophoblast in the placenta [7,50], where it plays an indispensable role in iron transfer to the fetus.”
BackgroundMcKie, A. T., Marciani, P., Rolfs, A., Brennan, K., Wehr, K., Barrow, D., Miret, S., Bomford, A., Peters, T. J., Farzaneh, F., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80425-6 · Cited by 1,422
Zimmermann, M. B., & Hurrell, R. F. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61235-5 · Cited by 1,405 · cited 1×
“Iron deficiency, iron deficiency anemia [65] and anemia of inflammation [66] are very common disorders affecting a large portion of the population.”
BackgroundDysmetabolic Hyperferritinemia: All Iron Overload Is Not Hemochromatosis
Makker, J., Hanif, A., Bajantri, B., & Chilimuri, S. (2015) · Case Reports in Gastroenterology · doi:10.1159/000373883 · Cited by 1,351
LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity
Krause, A., Neitz, S., Mägert, H.-J., Schulz, A., Forssmann, W.-G., Schulz-Knappe, P., & Adermann, K. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01920-7 · Cited by 1,324 · cited 1×
“Hepcidin can also kill microbes on contact in vitro [59,60] but the concentrations required for this direct microbicidal activity exceeded its concentrations in extracellular fluid, even in inflamed models.”
BackgroundA Novel Mammalian Iron-regulated Protein Involved in Intracellular Iron Metabolism
Abboud, S., & Haile, D. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000713200 · Cited by 1,267
Cited by
Items 301–400 of 530
Glucose induced regulation of iron transporters implicates kidney iron accumulation
Kumar, R., Kulshreshtha, D., Aggarwal, A., Asthana, S., Dinda, A. K., & Mukhopadhyay, C. K. (2024) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2024.130713 · Cited by 4
Liu, S., Ruan, L., Wang, G. H., Li, S. B., You, K., Chen, M. L., Lv, Z. Q., Pang, Y., Pu, L., Liu, X. Y., et al. (2025) · Science & Sports · doi:10.1016/j.scispo.2024.12.003 · Cited by 8
Deletion of hepcidin disrupts iron homeostasis and hematopoiesis in zebrafish embryogenesis
Yang, W., Peng, M., Wang, Y., Zhang, X., Li, W., Zhai, X., Wu, Z., Hu, P., & Chen, L. (2025) · Development · doi:10.1242/dev.204307 · Cited by 5
Kamińska-Gibas, T., Szczygieł, J., Blasweiler, A., Gajda, Ł., Yılmaz, E., Jurecka, P., Kolek, L., Ples, M., & Irnazarow, I. (2023) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2023.109087 · Cited by 2
Li, Y., Duan, F., & Yang, S. (2024) · BMC Medical Genomics · doi:10.1186/s12920-024-01929-0 · Cited by 2
“On the secondary structure, FPN consists of two 6-transmembrane-helix bundles, named as N-lobe and C-lobe, forming a central cavity for iron transport [20, 21].”
BackgroundSickinger, M., Joerling, J., Büttner, K., Roth, J., & Wehrend, A. (2025) · Animals · doi:10.3390/ani15071021 · Cited by 3
“Hepcidin is mainly produced by hepatocytes and is crucial for maintaining stable plasma iron concentrations and storage in the body’s iron reserves [66,67].”
Enhancing Survival Following High-Risk Surgery by Modulating Actionable Items within the Pathobiome
Zaborina, O. Y., Zaborin, A., Keskey, R. C., & Alverdy, J. C. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1010335 · Cited by 2
Role of Iron Metabolic Disturbances and Inflammatory Iron Biomarkers in Liver Transplant Prognosis
Yu, L., Xu, J., Que, T., Miao, Z. H., Zhou, Y., Que, S., Zheng, S., & Liu, Z. (2025) · International Journal of Medical Sciences · doi:10.7150/ijms.113479 · Cited by 4
“Synthesized predominantly in the liver, it exerts its regulatory function by binding to ferroportin, the sole known cellular iron exporter[37].”
Ilnicka-Borowczyk, K., Woźniak, D., Dobrzyńska, M., Podgórski, T., Szymanowski, K., Blask‐Osipa, A., Mieloszyk, K., & Drzymała-Czyż, S. (2025) · Nutrients · doi:10.3390/nu17193103 · Cited by 2
“This is primarily because its functional activity is tightly regulated by hepcidin levels, which modulate ferroportin activity [58].”
Hwang, H., Lee, M. H., Lee, S., Sung, B.-J., Kim, J., Seo, D. Y., Hur, D. Y., Yoo, Y. H., Cheong, J., & Kim, H. Y. (2025) · Toxics · doi:10.3390/toxics13110932 · Cited by 2
“Emerging evidence suggests crosstalk between iron metabolism and adipose inflammation, where inflammatory cytokines upregulate hepcidin, while iron accumulation enhances inflammatory signaling [20–22].”
Hauck, S. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1701625 · Cited by 3
“Chronic stress maintains low-grade IL-6 signaling, which upregulates hepatic hepcidin.”
Hepatokine FGL1 and hepcidin in anemia of chronic kidney disease: A cross sectional study
Saboor, M., Hashim, H. N., Guella, A., & Alkhayyal, N. (2025) · Journal of King Saud University - Science · doi:10.25259/jksus_1251_2025 · Cited by 2
Li, X., Xiao, W., Zhao, B., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-30995-2 · Cited by 2
Yuan, F., Han, Z., Yang, S., Chen, J., Li, R., Zhang, Z., Song, J., Wang, D., & Ban, Y. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1758041 · Cited by 7
“The ketogenic diet also suppressed iron metabolism disruption by reducing TFR1 and DMT1 expression while increasing FTH1 and FPN1 expression.”
InfluentialOłdakowska, A. K., Kamiński, K. A., & Ptaszyńska‐Kopczyńska, K. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27052333 · Cited by 2
“…small acute phase protein produced by the liver—prevents iron absorption in the duodenum by binding to the ferroportin, the only known receptor for iron, which enables its release to the bloodstream from enterocytes and from iron storage cells in the liver, the spleen, and bone marrow [54].”
Yan, P., Wang, J., Lei, Z., Chang, H., Shi, W., & Wang, S. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1709805 · Cited by 4
“…alveolar epithelial cells and alveolar macrophages mediate iron uptake primarily through the expression of DMT1, while hepcidin binds to FPN, inducing its ubiquitination and degradation, thereby inhibiting transmembrane iron export and controlling systemic iron availability (Nemeth and Ganz, 2021).”
Katikaneni, D. S., Arekar, T., Al-Hraki, L., Garcia, G., Reedy, N., Morel, L. M., Manolova, V., & Scindia, Y. M. (2026) · Clinical Immunology · doi:10.1016/j.clim.2026.110699 · Cited by 2
Iron Physiology and Its Impact on Atopic Diseases: An EAACI Taskforce Report
Roth‐Walter, F., Agache, I. O., Cabanillas, B., Canani, R. B., Comberiati, P., Garn, H., Gómez‐Casado, C., Hufnagl, K., Khaleva, E., Milani, G. P., et al. (2026) · Allergy · doi:10.1111/all.70325 · Cited by 4
“Dietary and individual-dependent factors strongly influence bioavailability [68, 309, 310].”
Non-coding RNAs as master regulators of ferroptosis in cancer: mechanisms and clinical implications
Mo, H., Xie, Y., Zhang, H. Z. H., Liu, Y., Wu, W., Xia, Z., Luo, P., Liu, Z., & Cheng, Q. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02666-x · Cited by 4
“Concurrently, it produces hepcidin, the master regulator of systemic iron homeostasis, which controls iron efflux by binding to and inducing the degradation of ferropor-tin [68, 69].”
GSH-Related Enzymes GPx4, Chac1, and GSTs and Redox Regulation of Ferroptosis in Cancer
Kalinina, E. V. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146353 · Cited by 3
“Ferroportin (FPN, also known as SLC40A1) exports cellular iron (Fe 2+ ) [61].”
The study on the main mode of the death of red blood cells in grass carp (Ctenopharyngodon idella)
Chen, H., Yao, M., Tang, Y., Wei, L., Lin, J., Shi, F., Zhan, F., Li, Y., Li, J., Lin, L., et al. (2022) · Aquaculture · doi:10.1016/j.aquaculture.2022.739071 · Cited by 2
Ramavath, H. N., Konda, V., & Pullakhandam, R. (2023) · Nutrients · doi:10.3390/nu15051205 · Cited by 4
“Alternatively, hepcidin, an iron hormone elevated during high iron stores, inhibits the iron absorption from enterocytes and egress from the liver and macrophages by inducing internalization and degradation of FPN1 [1,7].”
BackgroundMacrophage checkpoint for iron absorption
Pantopoulos, K. (2023) · Blood · doi:10.1182/blood.2023020167 · Cited by 3
Cheng, C.-Y., Hsu, T.-H., Yang, Y., & Huang, Y. (2023) · Children · doi:10.3390/children10081402 · Cited by 2
“As a result, anemia associated with inflammation can occur due to a combination of hepcidin-induced hypoferremia and cytokine-mediated inhibition of erythropoiesis, leading to a shortened lifespan of erythrocytes [23,26,27].”
BackgroundInfluentialKotak, K., Aggarwal, K., Garg, S., Gupta, V., Anamika, F., & Jain, R. (2023) · Cardiology in Review · doi:10.1097/crd.0000000000000603 · Cited by 2
“17,18 ID usually occurs due to reduced iron absorption, increased iron loss through the gastrointestinal tract, and limited access to usable iron from the reticuloendothelial system.”
Barad, A., Guillet, R., Pressman, E. K., Katzman, P. J., Ganz, T., Nemeth, E., & O'Brien, K. O. (2023) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2023.10.022 · Cited by 2
Self-citationOgawa, C., Tsuchiya, K., Tomosugi, N., & Maeda, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031508 · Cited by 3
“Two-tailed p -values less than 0.05 were considered to indicate statistically significant differences.”
BackgroundInfluentialIron deficiency, anemia and atrial fibrillation
Kachnov, V. A., Tyrenko, V. V., Bratilova, E. S., et al. (2024) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2024-001 · Cited by 2
Diagnostic Value of Hepcidin in Sepsis: A Systematic Review and Meta-Analysis
Zhang, J., Zheng, Z., Ren, L., Wang, C., Li, Y., Hu, X., Zhang, J., Jing, X., & Jin, Y. (2024) · Journal of Intensive Care Medicine · doi:10.1177/08850666241267261 · Cited by 2
Serum concentration of ferroportin in women of reproductive age
Ljubić, K., Penava, N., Tomić, V., Cvetković, I., Pušić, A., Mikulić, V., Mikulić, I., Ćuk, A., & Rumora, L. (2024) · Biochemia Medica · doi:10.11613/bm.2024.030701 · Cited by 3
“Ferroportin exports cellular iron by the mechanism of switching between an inward-open conformation that binds intracellular iron and an outward-open conformation that releases iron into the extracellular space (5).”
BackgroundSports Genomics and the Intersection of Genetics and Training in Sports
Vyas, S., & Mandapaka, R. T. (2024) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/979-8-3693-6317-1.ch012 · Cited by 2
Hepcidin promotes oral ulcer healing via amphiregulin production in rats
Taguchi, N., Hitomi, S., Sato, H., Hayashi, Y., Shibuta, I., Iwata, K., Shirota, T., & Shinoda, M. (2024) · Journal of Dental Sciences · doi:10.1016/j.jds.2024.12.001 · Cited by 2
“25 Therefore, to facilitate wound healing without adverse effects, local regulation of hepcidin levels is crucial.”
Rah, B., Shafarin, J., Qaisar, R., Karim, A., Hamad, M. A., & Muhammad, J. S. (2025) · Life Sciences in Space Research · doi:10.1016/j.lssr.2025.01.003 · Cited by 4
Elahi, P., Ahmad, M. I., & Falasca, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26030874 · Cited by 7
“…circulating iron levels by interacting with ferroportin, a transporter on the cell membrane that inhibits iron release from cellular storage [20]. system protein, decreases circulating iron levels by interacting with ferroportin, on the cell membrane that inhibits iron release from cellular…”
Zeng, L., Wang, Y., Ai, C., Liu, B., Yu, M.-H., Zhang, H., & Li, F. (2025) · Frontiers in Marine Science · doi:10.3389/fmars.2024.1530807 · Cited by 3
AAV-based vectors for human diseases modeling in laboratory animals
Aliev, T. I., & Yudkin, D. V. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2024.1499605 · Cited by 3
HFE-Related Hemochromatosis May Be a Primary Kupffer Cell Disease
Kouroumalis, E., Tsomidis, I., & Voumvouraki, A. (2025) · Biomedicines · doi:10.3390/biomedicines13030683 · Cited by 3
Chen, X., Wang, J., Zhen, C., Zhang, G., Yang, Z., Xu, Y., & Shang, P. (2025) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-025-08515-0 · Cited by 3
Lobbes, H., Pereira, B., Richard, M., Roux-Perceval, M., Durieu, I., & Reynaud, Q. (2025) · Scientific Reports · doi:10.1038/s41598-025-02296-1 · Cited by 3
“A major pathway of iron metabolism disorders in CF may be the systemic inflammation due to the recurrence of infectious events, inducing hepcidin secretion which in turn blocks iron absorption and bioavailability 32 .”
A Review of Wet Cupping’s Effects on Oxidative Stress and Insulin Resistance
Yu, I., Hur, J., Cho, J.-H., Yoo, H.-R., Choi, J., & Park, M. S. (2025) · 대한한의학회지 · doi:10.13048/jkm.25029 · Cited by 2
Wu, Z., Yao, T., Han, Z., Wang, Z., Liu, B., Lu, M., Zheng, J., & Shen, N. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.70422 · Cited by 6
“As a host defense mediator, hepcidin increases in response to infection and inflammation, blocking iron delivery through ferroprotein to blood plasma, thus limiting iron availability to invading microbes (Nemeth and Ganz 2021).”
Douba, Z. A., & Ibrahim, R. (2025) · Health Science Reports · doi:10.1002/hsr2.71148 · Cited by 3
“When hepcidin levels are abnormally high, blood iron decreases because iron becomes trapped within macrophages and liver cells, and iron absorption from the intestine is reduced [20, 21].”
The importance of iron deficiency and folic acid deficiency prevention upon pregnancy planning
Сергеевич, К. В., Kazenashev, V. V., Derevyanko, O. S., Тихомиров, А. Л., Рашитовна, Г. Л., Леонидовна, Д. Н., Владимировна, М. М., Lyapina, K. V., & Rurua, N. V. (2025) · Obstetrics Gynecology and Reproduction · doi:10.17749/2313-7347/ob.gyn.rep.2025.672 · Cited by 3
Hayashi, N., Nagastuka, H., Sato, M., & Goto, K. (2023) · Physical Activity and Nutrition · doi:10.20463/pan.2023.0020 · Cited by 2
Iron homeostasis in obesity and metabolic and bariatric surgery: a narrative review
Benotti, P. N., Kaberi‐Otarod, J., Wood, G. C., Gerhard, G. S., Still, C. D., & Bistrian, B. R. (2024) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2024.08.018 · Cited by 3
Structures of ferroportin in complex with its specific inhibitor vamifeportPreprint
Lehmann, E. F., Liziczai, M., Drożdżyk, K., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.29.505642 · Cited by 2
“Since a regulated excretion pathway of iron does not exist in mammals, its uptake, recycling, and redistribution are tightly regulated processes (Nemeth and Ganz, 2021).”
BackgroundGuo, W., Zhang, J., Zhang, X., et al. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4672421 · Cited by 2
Szczerbińska, A., Kasztelan‐Szczerbińska, B., Rycyk, A., & Cichoż‐Lach, H. (2024) · Preprints.org · doi:10.20944/preprints202402.1362.v1 · Cited by 2
Iron Overload Accompanying Extracellular Acidosis and NeurodegenerationPreprint
Ingrassia, R., & Garrick, M. D. (2024) · Preprints.org · doi:10.20944/preprints202406.0882.v1 · Cited by 2
Alvandi, M., Hashemi, S. H., Shaghaghi, Z., Marzhoseyni, Z., Ghasemi-Basir, H. R., Mohammadi, M., Ahmadieh-Yazdi, A., & Farzipour, S. (2024) · Coronaviruses · doi:10.2174/0126667975288661240123075201 · Cited by 1
Sugiura, S. H., & Satoh, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-90873-3.00014-2 · Cited by 2
Li, M., Zhao, M., Zhang, C., Ji, Q., Wang, X., Du, Y., Chen, K., Ji, F., Huang, S., & Guo, R. (2025) · Frontiers in Animal Science · doi:10.3389/fanim.2025.1569306 · Cited by 2
“The regulation of iron metabolism is a complex process that is orchestrated by a variety of proteins, including divalent metal transporter and hepcidin (Nemeth and Ganz, 2021).”
Huang, C. X., Zhang, Z., He, J., Zhong, Z., Ma, Y., Huang, X., Xia, F., Tan, H., Deng, J., & Chen, M. (2025) · Nutrients · doi:10.3390/nu17111938 · Cited by 3
“Hepcidin interacts with ferritin on enterocytes, triggering their internalization and proteolytic degradation and ultimately inhibiting iron absorption by intestinal epithelial cells [57,58].”
Iron Metabolism in Cardiovascular Disease
Kalousdian, A., Ardehali, M. M., & Ardehali, H. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-92033-2_15 · Cited by 2
Huang, B., Ding, X., Wen, W., & Ye, S. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s523961 · Cited by 3
“18 Disruptions in systemic iron balance, including iron overload and deficiency, have detrimental effects on kidney function, and studies have shown increased iron deposition in the TECs of DKD patients compared to healthy individuals.”
Feo, G. D., Giliberti, G., Rana-Seyfert, D., Marrapodi, M. M., Casale, M., Ahmed, S., Perrotta, S., Rossi, F., Roberti, D., & Paola, A. D. (2025) · Scientific Reports · doi:10.1038/s41598-025-15028-2 · Cited by 1
Fujiwara, T., & Harigae, H. (2025) · Molecular and Cellular Biology · doi:10.1080/10985549.2025.2553648 · Cited by 1
“21,22 In developing erythroid cells, it permits dynamic regulation of iron availability by enabling iron efflux, which may allow redistribution of iron to other tissues, rather than strict retention within the erythroid lineage.”
Erdoğdu, B., Kaplan, O., Çelebier, M., Malkan, Ü. Y., & Haznedaroğlu, İ. C. (2025) · Medicina · doi:10.3390/medicina61091687 · Cited by 3
“A central regulator of systemic iron homeostasis is hepcidin, which limits iron availability for erythropoiesis through its binding to ferroportin [158].”
Qian, H., Wang, P., Li, Y., Zhang, C., Li, J., Wang, Q., Ren, H., Jin, F., Huang, J., Yao, J., et al. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47100843 · Cited by 1
“In contrast, systemic regulation of iron homeostasis is regulated through the ferromodulin/ferric transfer protein (FPN) axis [9–11], which maintains stable body iron levels and plasma iron concentrations.”
Estimation of New Regulators of Iron Metabolism in Short-Term Follow-Up After Bariatric Surgery
Kupczyk, W., Boińska, J., Słomka, A., Kupczyk, K., Jackowski, M., & Żekanowska, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110543 · Cited by 2
“Elevated hepcidin levels downregulate ferroportin, the major cellular iron exporter, which in turn restricts iron availability and promotes iron deficiency, especially when combined with dietary habits that limit iron intake [8].”
Iron metabolism and ferroptosis: druggable targets to delay the progression of lupus nephritis
Al-Hraki, L., Morel, L. M., & Scindia, Y. M. (2025) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00229.2025 · Cited by 1
Maternal obesity during pregnancy disrupts iron homeostasis and promotes fetal hypoxia in the mouse
Córdova-Casanova, A., Inzani, I., Hufnagel, A., Giussani, D. A., Fernandez‐Twinn, D. S., & Ozanne, S. E. (2025) · The Journal of Physiology · doi:10.1113/jp288635 · Cited by 4
“The sequestration of iron in these compartments reduces its bioavailability for iron-dependent processes (Nemeth & Ganz, 2021).”
Hamada, N., Ito, Y., Niimi, H., Atarashi, M., Kuwamura, M., Taguchi, K., Yamamoto, M., & Izawa, T. (2025) · Toxicological Sciences · doi:10.1093/toxsci/kfaf165 · Cited by 1
Iron deficiency anemia in suckling piglets: When physiology cannot keep up with breeding goals
Lipiński, P., Starzyński, R. R., Lenartowicz, M., Wang, X., Ogłuszka, M., & Batorska, M. (2025) · The Veterinary Journal · doi:10.1016/j.tvjl.2025.106530 · Cited by 4
Huang, T., Xiao, X., Ma, J., Fang, J., & Bao, Y. (2026) · European journal of medical research · doi:10.1186/s40001-026-03871-6 · Cited by 1
“Because hepcidin has been shown to have an inhibitory effect on the expression of TfR1 in different types of cells [31, 48, 49].”
Al-Helo, H., Desai, S. A., Varma, T., Garg, P., & Shahiwala, A. (2026) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2026.100220 · Cited by 2
Abediasl, M., Siavash, M., Esfahani, S. S., Amini, Z., Amiri, K., Saket, S., Esmaeili, E., Rafizadeh, F., Saraei, R., & Fakhr, M. S. (2026) · Clinical & Translational Oncology · doi:10.1007/s12094-026-04225-8 · Cited by 3
“…internalization and degradation on enterocytes and macrophages, thereby reducing iron export to plasma and limiting transferrin-bound iron [15] the colon, elevated NTBI levels may exacerbate mucosal injury and promote carcinogenesis, especially when co-existing with inflammation or…”
Yang, Y., Yang, F., Yao, M., Li, L., & Li, H. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261427028 · Cited by 2
“38,39 When Fe 2 + accumulates abnormally in the LIP, iron overload triggers the Fenton reaction, leading to excessive generation of hydroxyl radicals (-”
Phosphatidylserine Decarboxylase Promotes Ferroptosis Through STAT3/GPX4 Signaling in Gastric Cancer
Wang, L., Wang, Y., Shao, M., Wang, T., Zheng, W., Cao, J., Luo, R., Tu, Y., Xia, Y., Wei, Y., et al. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48030300 · Cited by 1
“Hepcidin binds to the iron exporter ferroportin (FPN1/SLC40A1) and promotes its internalization and degradation, thereby limiting iron export and favoring intracellular iron retention [40].”
Hemochromatosis osteoarthritis
Yang, Y., Zu, Z., & Huang, Y. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1735750 · Cited by 1
“Hepcidin is a critical peptide hormone secreted by liver cells that centrally regulates systemic iron homeostasis by modulating the activity of ferroportin (22).”
Serum Erythroferrone Level and Its Relation to Iron Overload in Patients with Βeta-Thalassemia
Salama, M., Hassab, H., Balbaa, N., Ettaby, A. N., Saad, N., & Hassanein, N. M. (2026) · Journal of Applied Hematology · doi:10.4103/joah.joah_10_26 · Cited by 2
Blagojevic, N., Blagojevic, D., Matovic, A., Cvrkotic, M., Marjanovic-Haljilji, M., Šljivić, A., Ilić, A., Cvetinovic, N., Nenadic, I. N., Djuric, M. D., et al. (2026) · Antioxidants · doi:10.3390/antiox15040490 · Cited by 1
“Hepatic ferroptosis further accelerates fibrosis, illustrating how iron-driven oxidative injury simultaneously amplifies both hepatic and cardiac pathology [21,60–64].”
Alhawiti, N. M. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1728096 · Cited by 3
“Collectively, platelet hyperactivity, iron-induced oxidative stress, and chronic inflammation form interconnected pathogenic pathways that drive the progression of MASLD/MASH, liver cirrhosis, and hepatocellular carcinoma (77, 83, 84).”
Iron Overload: Pathophysiology, Diagnosis and Monitoring
Chatzikalil, E., Delaporta, P., Bistas, K., & Kattamis, A. (2026) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.70132 · Cited by 3
“The complexity of hepcidin regulation partially explains the absence of disease modifiers, although co-factors like alcohol or viral hepatitis may directly suppress hepcidin production worsening deficiency [31].”
García‐Erce, J. A., García‐López, S., & Martínez‐Francés, A. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15103691 · Cited by 4
“This interaction decreases iron efflux into the plasma when body iron levels are sufficient [27–29].”
Iron dysregulation in the central nervous system: implications for autism spectrum disorder
Bjørklund, G., Harutyunyan, H. S., Mkrtchyan, Z., Baghdasaryan, E., Avetisyan, T., Meguid, N. A., Hussein, F., & Yenkoyan, K. B. (2026) · BioMetals · doi:10.1007/s10534-026-00833-7 · Cited by 3
“The latter occurs via ferroportin, which is regulated by hepcidin, a liver-derived peptide (Nemeth & Ganz 2021).”
Chaubey, G. K., Dilawari, R., Modanwal, R., Talukdar, S., Dhiman, A., Patidar, A., Chaudhary, S., Sindhu, A., Kumar, A., Raje, C. I., et al. (2026) · iScience · doi:10.1016/j.isci.2026.116156 · Cited by 1
Tomoiagă, A.-V., Suciu, S., Gerdanovics, C.-A., Gerdanovics, A., Milaciu, M. V., Perné, M.-G., Alexescu, T., Ciumărnean, L., Cozma, A., Negrean, V., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27125318 · Cited by 1
“Hepcidin synthesis is upregulated in response to increased plasma and hepatic iron levels, as well as during inflammation, primarily through activation of the IL-6/STAT3 signaling pathway [27,28,30].”
Kaldarkhan, D., Nuskabayeva, G. O., Nurdinov, N. S., Tatykayeva, U. B., Oshibayeva, A., Isanova, S., Mamutova, A. Y., Özkul, Y., Gökçe, N., Şahin, İ. O., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27125374 · Cited by 1
“Systemic iron homeostasis is regulated by the hepcidin–ferroportin axis, which controls intestinal iron absorption, iron recycling from senescent erythrocytes, and the release of iron from hepatic stores [3].”
Cell death mechanisms in sepsis-associated adaptive immune dysfunction
Li, X., Qian, W., Cao, N., & He, Y. (2026) · Journal of Critical Care · doi:10.1016/j.jcrc.2026.155696 · Cited by 1
Obesity and Iron Metabolism: Mechanisms, Status Assessment, and Clinical Implications
Aguree, S., & Meng, X. (2026) · Current Obesity Reports · doi:10.1007/s13679-026-00753-0 · Cited by 2
“When sustained, this process produces hypoferremia [9, 19].”
SAVINA, V., & SAVIN, E. Y. (2012) · Psychological Science and Education psyedu.ru · Cited by 1
Iron supplementation in women: impact of frequency on efficacy and tolerability
McDonald, E. M., Moore, A.-R. E., & Ram, F. S. (2022) · British Journal of General Practice · doi:10.3399/bjgp22x719045 · Cited by 2
Iron deficiency and postcovid syndrome: a clinical case
Polyakova, O. A., Клепикова, М. В., Doldo, N. M., Isaakyan, Y. A. I., & Ostroumova, O. D. (2022) · Medical alphabet · doi:10.33667/2078-5631-2022-25-34-40 · Cited by 1
Is the Benefit of Treating Iron Deficiency Greater in Acute Heart Failure with Renal Dysfunction?
López‐Vilella, R., Cervera, B. G., Trenado, V. J. D., et al. (2023) · Life · doi:10.3390/life13040915 · Cited by 1
“1 patients to obtain the benefit of the combined event [31,32].”
BackgroundWang, Q., Li, J., Ma, W., Sun, L., Zhang, B., Zhao, Y., & Zhang, S. (2023) · Toxicology Letters · doi:10.1016/j.toxlet.2023.09.009 · Cited by 1
Sharafutdinova, D. R., Lutfullina, R. A., Boldyreva, A. M., Krogh-Jensen, O. A., Ionov, О. V., & Degtyarev, D. N. (2023) · Neonatology News Opinions Training · doi:10.33029/2308-2402-2023-11-3-38-46 · Cited by 1
Huang, X., Chen, H., Tu, C.-W., Zhang, L., Liu, L., Lin, L., Qin, Z., & Zhan, F. (2024) · Aquaculture and Fisheries · doi:10.1016/j.aaf.2024.03.011 · Cited by 3
Scientific substantiation of the use of iron-containing drugs in veterinary medicine
Деркач, І. М., Dukhnitsky, V., Fritsky, I. O., et al. (2024) · Ukrainian journal of veterinary sciences · doi:10.31548/veterinary2.2024.27 · Cited by 1
Thornton, J. A., Koc, Z. C., Sollars, V. E., Valentovic, M. A., Denvir, J., Wilkinson, J., & Koc, E. C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158344 · Cited by 2
Regulation of Intestinal Iron Absorption: Balancing Supply and Demand
Yaseen, S., Akram, R. H., Ali, B., Zaheer, K., Rafique, M., Eman, P., Fatima, N., Kausar, F., & Luqman, M. (2024) · Futuristic Biotechnology · doi:10.54393/fbt.v4i03.149 · Cited by 2
Zhao, R., Zhu, J., Li, S., Sun, Z., Zhang, T., Wang, J., Zheng, X., Kuang, Y., & Wang, D. (2025) · Antioxidants · doi:10.3390/antiox14040443 · Cited by 1
“In this study, we found that the mortality rate of WUCI was slightly higher than that of WT infected with A. hydrophila lasting 14 days.”
Garanin, A. A., Bogacheva, T. E., & Громова, О. А. (2025) · Pharmacokinetics and Pharmacodynamics · doi:10.37489/2587-7836-2025-1-17-26 · Cited by 1
Introduction to Iron Dynamics in Human Cells: Fundamental Mechanisms and Recent Developments
Yanatori, I., & Sawai, H. (2025) · Royal Society of Chemistry eBooks · doi:10.1039/9781837677979-00001 · Cited by 3
Łęcka, M., Słomka, A., Albrecht, K., Romiszewski, M., & Styczyński, J. (2025) · Cancers · doi:10.3390/cancers17152495 · Cited by 4
Iron accumulation in ferroptosis and the role of lipid peroxidation in osteoarthritis
Shang, T. (2023) · International Journal of Frontiers in Medicine · doi:10.25236/ijfm.2023.050314
Assessment of the Serum Hepcidin as a Biomarker of Iron Status in Pediatric Congestive Heart Failure
shedeed, S., Khalifa, N., Mohammed, M. A., et al. (2023) · Zagazig University Medical Journal · doi:10.21608/zumj.2023.238708.2919 · Cited by 1
BIOCHEMICAL MECHANISMS OF FERROPTOSIS
Nikolaev, A. A. (2023) · Molekulyarnaya Meditsina (Molecular medicine) · doi:10.29296/24999490-2023-02-03 · Cited by 2
Yang, W.-P., Li, M.-Q., Ding, J. M., Li, J., Wu, G., Liu, B., Gao, Y., Wang, G., & Luo, Q. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.23.533972 · Cited by 1
Smith, J. G., Molendijk, J., Blazev, R., Chen, W. H., Zhang, Q., Litwin, C., Greco, C. M., Sassone‐Corsi, P., Muñoz‐Cánoves, P., Parker, B. L., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.12.544652 · Cited by 1
Metadata
- Authors
- Nemeth, E., & Ganz, T.
- Affiliations
- University of California, Los Angeles (US)
- Corresponding author
- Ganz, Tomas
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-06-17
- Volume
- 22
- Issue
- 12
- Pages
- 6493
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8235187
- OpenAlex
- W3172506357
- Semantic Scholar
- 8da9eb7ee1579f5db94cd40eca5fde949bb5967c
- Cited by
- 540
- References
- 69
- Citations by year
- 2026: 101 · 2025: 143 · 2024: 107 · 2023: 110 · 2022: 71 · 2021: 7
- FWCI
- 12.91
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD096863)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- hepcidin, ferroportin, SLC40A1, iron homeostasis, iron export, hypoferremia, compensatory erythropoiesis, iron deficiency, hereditary hemochromatosis, inflammation, infection, iron overload, iron recycling, macrophages, hepatocytes
- MeSH terms
- Ferroportin, Animals, Biological Transport, Disease Susceptibility, Homeostasis, Humans, Iron, Ligands, Protein Binding, Tissue Distribution, Signal Transduction, Autocrine Communication, Paracrine Communication, Cation Transport Proteins, Metabolic Networks and Pathways, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.